AU617088B2 - Peptides involved in the pathogenesis of hiv infection - Google Patents

Peptides involved in the pathogenesis of hiv infection

Info

Publication number
AU617088B2
AU617088B2 AU75404/87A AU7540487A AU617088B2 AU 617088 B2 AU617088 B2 AU 617088B2 AU 75404/87 A AU75404/87 A AU 75404/87A AU 7540487 A AU7540487 A AU 7540487A AU 617088 B2 AU617088 B2 AU 617088B2
Authority
AU
Australia
Prior art keywords
pathogenesis
hiv infection
peptides involved
peptides
involved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU75404/87A
Other versions
AU7540487A (en
Inventor
Richard A. Fisher
Kuzhalmannam L. Ramachandran
Vicki L. Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of AU7540487A publication Critical patent/AU7540487A/en
Application granted granted Critical
Publication of AU617088B2 publication Critical patent/AU617088B2/en
Assigned to BIOGEN, INC. reassignment BIOGEN, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: BIOGEN, INC., Gilber, Walter
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU75404/87A 1986-06-12 1987-06-09 Peptides involved in the pathogenesis of hiv infection Ceased AU617088B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87362186A 1986-06-12 1986-06-12
US873621 1986-06-12
US4193687A 1987-04-24 1987-04-24
US041936 1987-04-24

Publications (2)

Publication Number Publication Date
AU7540487A AU7540487A (en) 1988-01-11
AU617088B2 true AU617088B2 (en) 1991-11-21

Family

ID=26718709

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75404/87A Ceased AU617088B2 (en) 1986-06-12 1987-06-09 Peptides involved in the pathogenesis of hiv infection

Country Status (5)

Country Link
EP (1) EP0269712A4 (en)
JP (1) JPH01501547A (en)
AU (1) AU617088B2 (en)
NZ (1) NZ220653A (en)
WO (1) WO1987007616A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667078B2 (en) * 1992-03-26 1996-03-07 New York Blood Center, Inc., The Synthetic polypeptides as inhibitors of HIV-1

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126399A (en) * 1986-04-30 1992-06-30 Board Of Regents, The University Of Texas System Methods and compositions for the preparation and use of site-directed immunologic reagents
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
US5166050A (en) * 1986-08-20 1992-11-24 Bristol-Myers Squibb Company Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
US5976541A (en) * 1988-01-26 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
NO881151L (en) * 1987-03-27 1988-09-28 Syntello Ab SYNTHETIC HIV-1 ANTIGEN.
FI872409A0 (en) * 1987-05-29 1987-05-29 Labsystems Oy FOERFARANDE FOER DETEKTERING AV HIV-1 MOTKROPPAR.
US5820865A (en) * 1988-01-26 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides
JP2569185B2 (en) * 1988-01-26 1997-01-08 アメリカ合衆国 Synthetic antigen eliciting anti-HIV response
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
WO1990003984A1 (en) * 1988-10-03 1990-04-19 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
CA2051107A1 (en) * 1989-04-25 1990-10-26 William N. Sun Antibodies specific for cd4-binding domain of hiv
US6309880B1 (en) * 1989-04-25 2001-10-30 Tanox, Inc. Antibodies specific for CD4-binding domain of HIV-1
GB8912496D0 (en) * 1989-05-31 1989-07-19 Medical Res Council Vaccines
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
HU9300877D0 (en) * 1990-09-27 1993-06-28 Syntello Vaccine Dev Kb Method for producing proteines applicables by injection and inducing anti-bodies having neutralizing effect against virus of human immun insufficiency
US5840313A (en) * 1990-09-27 1998-11-24 Syntello Vaccine Development Kb Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
AU662534B2 (en) * 1991-06-03 1995-09-07 Syntello Vaccine Development Ab Peptides for use in induction of T cell activation against HIV-1
DE69311764T2 (en) * 1992-05-14 1998-02-05 Polymun Scient Immunbio Forsch Peptides that induce antibodies that neutralize genetically divergent HIV-1 isolations
AU667578B2 (en) * 1992-08-27 1996-03-28 Deakin Research Limited Retro-, inverso-, and retro-inverso synthetic peptide analogues
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
FR2717081B1 (en) * 1994-03-14 1996-06-21 Centre Nat Rech Scient Retropeptides, antibodies to the latter, and their uses for vaccination and in vitro diagnosis.
CA2235168A1 (en) * 1995-10-20 1997-04-24 Duke University Synthetic vaccine for protection against human immunodeficiency virus infection
US6749856B1 (en) 1997-09-11 2004-06-15 The United States Of America, As Represented By The Department Of Health And Human Services Mucosal cytotoxic T lymphocyte responses
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
NZ507083A (en) * 1998-03-23 2003-10-31 Trimeris Inc Methods and compositions for peptide synthesis, in particular T-20 (DP-178) and T-20-like peptides
ES2366185T3 (en) * 2003-04-11 2011-10-18 Institut Pasteur SYNTHETIC PEPTIDES VACCINES FOR HIV: THE EPDOPE OF CBD AS AN EFFECTIVE IMMUNOGEN TO PROVIDE WIDE NEUTRALIZING ANTIBODIES AGAINST HIV.
US20060205070A1 (en) * 2004-01-13 2006-09-14 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services HIV TEV compositions and methods of use
EP1714153A2 (en) * 2004-02-06 2006-10-25 I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
WO2007039458A2 (en) * 2005-09-21 2007-04-12 Cytos Biotechnology Ag Hiv peptide conjugates and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6299286A (en) * 1985-09-25 1987-04-09 Shiu-Lok Hu Vaccines against acquired immune deficiency syndrome
AU6399786A (en) * 1985-10-17 1987-04-30 F. Hoffmann-La Roche Ag Polypeptides used in the diagnosis and therapy of AIDS
AU6818987A (en) * 1986-02-03 1987-08-06 F. Hoffmann-La Roche Ag Htlv-iii envelope peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64006B1 (en) * 1984-10-18 1995-06-28 Pasteur Institut Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6299286A (en) * 1985-09-25 1987-04-09 Shiu-Lok Hu Vaccines against acquired immune deficiency syndrome
AU6399786A (en) * 1985-10-17 1987-04-30 F. Hoffmann-La Roche Ag Polypeptides used in the diagnosis and therapy of AIDS
AU6818987A (en) * 1986-02-03 1987-08-06 F. Hoffmann-La Roche Ag Htlv-iii envelope peptides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667078B2 (en) * 1992-03-26 1996-03-07 New York Blood Center, Inc., The Synthetic polypeptides as inhibitors of HIV-1

Also Published As

Publication number Publication date
EP0269712A1 (en) 1988-06-08
JPH01501547A (en) 1989-06-01
WO1987007616A1 (en) 1987-12-17
EP0269712A4 (en) 1990-06-26
AU7540487A (en) 1988-01-11
NZ220653A (en) 1990-06-26

Similar Documents

Publication Publication Date Title
AU617088B2 (en) Peptides involved in the pathogenesis of hiv infection
AU588672B2 (en) Ceramics
AU7956487A (en) Peptide derivatives
AU585812B2 (en) Divergent single filer
AU7668187A (en) N-phenylbutenamides with pharmaceutical properties
AU2157888A (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
AU1382488A (en) Cyclic peptides and their preparation
AU7851687A (en) Anti-inflammatory peptides
AU5449590A (en) Anti-hiv drug
AU7635887A (en) Recombinant HTLV-III proteins and uses thereof
AU573472B2 (en) Button
AU2937489A (en) Anti-hiv agent
AU604793B2 (en) Env/gag-polypeptides
AU7395987A (en) Vaccine
AU600015B2 (en) Stacker
AU7713387A (en) Hepatitis vaccine
AU7993087A (en) Protein purification
AU7984487A (en) Pharmaceutical combination
AU7843287A (en) Novel preparation
AU1101688A (en) Improvements in or relating to the handling of limp fabric
AU8129987A (en) Pyrrolo-benzimidazoles, their preparation and use
AU7044387A (en) Molluscicides
AU1676288A (en) Human immunodeficiency virus gag-encoded proteins
AU8268887A (en) Aminoethylisoxazolidines, their preparation and use
AU6516186A (en) Garment